A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins

Rene Rijnbrand, Yan Yang, Lucy Beales, Francis Bodola, Kathryn Goettge, Lisette Cohen, Robert E. Lanford, Stanley M. Lemon, Annette Martin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Only humans and chimpanzees are fully permissive for replication of hepatitis C virus (HCV), an important cause of liver cirrhosis and cancer worldwide. The absence of suitable animal models limits opportunities for in vivo evaluation of candidate hepatitis C therapeutics and slows progress in the field. Here, we describe a chimeric virus derived from GB virus B (GBV-B), an unclassified hepatotropic member of the family Flaviviridae that is closely related to HCV and infects tamarins (Saguinus sp.), in which a functionally important HCV regulatory sequence replaced an analogous sequence in the 5′ nontranslated region (5′NTR) of the GBV-B genome. The transplanted sequence comprised domain III of the internal ribosome entry site (IRES), which directly binds the 40S ribosome subunit and is a target for candidate therapeutics. The chimeric 5′NTR retained ribosome binding activity and was competent in directing protein translation both in cell-free translation reactions and in transfected primary tamarin hepatocyte cultures. Virus rescued from the chimeric RNA replicated in the liver of tamarins, causing biochemical and histopathological changes typical of viral hepatitis. However, adaptive mutations were required elsewhere in the genome for efficient replication. Virus was not rescued from other, translationally competent, chimeric RNAs in which domain II of the IRES was exchanged. Thus, the 5′NTR appears to contain virus-specific replication signals that interact with other sites within the viral genome or with viral proteins. In conclusion, such novel chimeric flaviviruses offer opportunities for new insights into HCV replication mechanisms, while potentially facilitating the evaluation of candidate therapeutics in vivo.

Original languageEnglish (US)
Pages (from-to)986-994
Number of pages9
JournalHepatology
Volume41
Issue number5
DOIs
StatePublished - May 2005
Externally publishedYes

Fingerprint

GB virus B
Untranslated RNA
Hepacivirus
Hepatitis
Virus Replication
Viruses
Saguinus
Eukaryotic Small Ribosome Subunits
Flaviviridae
Genome
RNA
Flavivirus
Pan troglodytes
Viral Genome
Protein Biosynthesis
Viral Proteins
Liver Neoplasms
Hepatitis C
Ribosomes
Liver Cirrhosis

ASJC Scopus subject areas

  • Hepatology

Cite this

Rijnbrand, R., Yang, Y., Beales, L., Bodola, F., Goettge, K., Cohen, L., ... Martin, A. (2005). A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Hepatology, 41(5), 986-994. https://doi.org/10.1002/hep.20656

A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. / Rijnbrand, Rene; Yang, Yan; Beales, Lucy; Bodola, Francis; Goettge, Kathryn; Cohen, Lisette; Lanford, Robert E.; Lemon, Stanley M.; Martin, Annette.

In: Hepatology, Vol. 41, No. 5, 05.2005, p. 986-994.

Research output: Contribution to journalArticle

Rijnbrand, R, Yang, Y, Beales, L, Bodola, F, Goettge, K, Cohen, L, Lanford, RE, Lemon, SM & Martin, A 2005, 'A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins', Hepatology, vol. 41, no. 5, pp. 986-994. https://doi.org/10.1002/hep.20656
Rijnbrand, Rene ; Yang, Yan ; Beales, Lucy ; Bodola, Francis ; Goettge, Kathryn ; Cohen, Lisette ; Lanford, Robert E. ; Lemon, Stanley M. ; Martin, Annette. / A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. In: Hepatology. 2005 ; Vol. 41, No. 5. pp. 986-994.
@article{9e23708cd5684ff8a737f5c031bb21c4,
title = "A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins",
abstract = "Only humans and chimpanzees are fully permissive for replication of hepatitis C virus (HCV), an important cause of liver cirrhosis and cancer worldwide. The absence of suitable animal models limits opportunities for in vivo evaluation of candidate hepatitis C therapeutics and slows progress in the field. Here, we describe a chimeric virus derived from GB virus B (GBV-B), an unclassified hepatotropic member of the family Flaviviridae that is closely related to HCV and infects tamarins (Saguinus sp.), in which a functionally important HCV regulatory sequence replaced an analogous sequence in the 5′ nontranslated region (5′NTR) of the GBV-B genome. The transplanted sequence comprised domain III of the internal ribosome entry site (IRES), which directly binds the 40S ribosome subunit and is a target for candidate therapeutics. The chimeric 5′NTR retained ribosome binding activity and was competent in directing protein translation both in cell-free translation reactions and in transfected primary tamarin hepatocyte cultures. Virus rescued from the chimeric RNA replicated in the liver of tamarins, causing biochemical and histopathological changes typical of viral hepatitis. However, adaptive mutations were required elsewhere in the genome for efficient replication. Virus was not rescued from other, translationally competent, chimeric RNAs in which domain II of the IRES was exchanged. Thus, the 5′NTR appears to contain virus-specific replication signals that interact with other sites within the viral genome or with viral proteins. In conclusion, such novel chimeric flaviviruses offer opportunities for new insights into HCV replication mechanisms, while potentially facilitating the evaluation of candidate therapeutics in vivo.",
author = "Rene Rijnbrand and Yan Yang and Lucy Beales and Francis Bodola and Kathryn Goettge and Lisette Cohen and Lanford, {Robert E.} and Lemon, {Stanley M.} and Annette Martin",
year = "2005",
month = "5",
doi = "10.1002/hep.20656",
language = "English (US)",
volume = "41",
pages = "986--994",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins

AU - Rijnbrand, Rene

AU - Yang, Yan

AU - Beales, Lucy

AU - Bodola, Francis

AU - Goettge, Kathryn

AU - Cohen, Lisette

AU - Lanford, Robert E.

AU - Lemon, Stanley M.

AU - Martin, Annette

PY - 2005/5

Y1 - 2005/5

N2 - Only humans and chimpanzees are fully permissive for replication of hepatitis C virus (HCV), an important cause of liver cirrhosis and cancer worldwide. The absence of suitable animal models limits opportunities for in vivo evaluation of candidate hepatitis C therapeutics and slows progress in the field. Here, we describe a chimeric virus derived from GB virus B (GBV-B), an unclassified hepatotropic member of the family Flaviviridae that is closely related to HCV and infects tamarins (Saguinus sp.), in which a functionally important HCV regulatory sequence replaced an analogous sequence in the 5′ nontranslated region (5′NTR) of the GBV-B genome. The transplanted sequence comprised domain III of the internal ribosome entry site (IRES), which directly binds the 40S ribosome subunit and is a target for candidate therapeutics. The chimeric 5′NTR retained ribosome binding activity and was competent in directing protein translation both in cell-free translation reactions and in transfected primary tamarin hepatocyte cultures. Virus rescued from the chimeric RNA replicated in the liver of tamarins, causing biochemical and histopathological changes typical of viral hepatitis. However, adaptive mutations were required elsewhere in the genome for efficient replication. Virus was not rescued from other, translationally competent, chimeric RNAs in which domain II of the IRES was exchanged. Thus, the 5′NTR appears to contain virus-specific replication signals that interact with other sites within the viral genome or with viral proteins. In conclusion, such novel chimeric flaviviruses offer opportunities for new insights into HCV replication mechanisms, while potentially facilitating the evaluation of candidate therapeutics in vivo.

AB - Only humans and chimpanzees are fully permissive for replication of hepatitis C virus (HCV), an important cause of liver cirrhosis and cancer worldwide. The absence of suitable animal models limits opportunities for in vivo evaluation of candidate hepatitis C therapeutics and slows progress in the field. Here, we describe a chimeric virus derived from GB virus B (GBV-B), an unclassified hepatotropic member of the family Flaviviridae that is closely related to HCV and infects tamarins (Saguinus sp.), in which a functionally important HCV regulatory sequence replaced an analogous sequence in the 5′ nontranslated region (5′NTR) of the GBV-B genome. The transplanted sequence comprised domain III of the internal ribosome entry site (IRES), which directly binds the 40S ribosome subunit and is a target for candidate therapeutics. The chimeric 5′NTR retained ribosome binding activity and was competent in directing protein translation both in cell-free translation reactions and in transfected primary tamarin hepatocyte cultures. Virus rescued from the chimeric RNA replicated in the liver of tamarins, causing biochemical and histopathological changes typical of viral hepatitis. However, adaptive mutations were required elsewhere in the genome for efficient replication. Virus was not rescued from other, translationally competent, chimeric RNAs in which domain II of the IRES was exchanged. Thus, the 5′NTR appears to contain virus-specific replication signals that interact with other sites within the viral genome or with viral proteins. In conclusion, such novel chimeric flaviviruses offer opportunities for new insights into HCV replication mechanisms, while potentially facilitating the evaluation of candidate therapeutics in vivo.

UR - http://www.scopus.com/inward/record.url?scp=17844390351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844390351&partnerID=8YFLogxK

U2 - 10.1002/hep.20656

DO - 10.1002/hep.20656

M3 - Article

C2 - 15793797

AN - SCOPUS:17844390351

VL - 41

SP - 986

EP - 994

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -